1069 — China Health Technology Holding Co Income Statement
0.000.00%
Last trade - 00:00
- HK$48.70m
- HK$167.65m
- CNY58.72m
- 18
- 69
- 18
- 23
2018 December 31st | 2019 December 31st | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 18 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 51.4 | 54.3 | 0 | 6.76 | 58.7 |
Cost of Revenue | |||||
Gross Profit | 28.1 | 34.8 | 0 | 0 | 11.5 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 100 | 372 | 513 | 5.92 | 56.4 |
Operating Profit | -48.7 | -317 | -513 | 0.836 | 2.31 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -77.1 | -340 | -547 | -20.4 | -9.37 |
Provision for Income Taxes | |||||
Net Income After Taxes | -65.3 | -340 | -547 | -20.4 | -10.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -65.3 | -340 | -554 | -18.9 | -10.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -65.3 | -340 | -554 | -18.9 | -10.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.549 | -2.79 | -0.564 | -0.297 | -0.322 |
Dividends per Share |